292 related articles for article (PubMed ID: 21173098)
1. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
[TBL] [Abstract][Full Text] [Related]
2. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
3. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
[TBL] [Abstract][Full Text] [Related]
4. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.
Bozzini C; Campostrini N; Trombini P; Nemeth E; Castagna A; Tenuti I; Corrocher R; Camaschella C; Ganz T; Olivieri O; Piperno A; Girelli D
Blood Cells Mol Dis; 2008; 40(3):347-52. PubMed ID: 18164223
[TBL] [Abstract][Full Text] [Related]
5. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
6. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
7. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
8. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
9. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
[TBL] [Abstract][Full Text] [Related]
10. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
[TBL] [Abstract][Full Text] [Related]
11. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
12. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
13. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
[TBL] [Abstract][Full Text] [Related]
15. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
16. HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping.
Koefoed P; Dalhoff K; Dissing J; Kramer I; Milman N; Pedersen P; Simonsen K; Tygstrup N; Nielsen FC
Scand J Clin Lab Invest; 2002; 62(7):527-35. PubMed ID: 12512743
[TBL] [Abstract][Full Text] [Related]
17. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
18. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
[TBL] [Abstract][Full Text] [Related]
19. HFE mutations, iron deficiency and overload in 10,500 blood donors.
Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]